{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:06:51Z","timestamp":1781766411566,"version":"3.54.5"},"reference-count":71,"publisher":"IMR Press","issue":"10","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health (NIH)\/National Heart, Lung, and Blood Institute","award":["R01 #HL155718-01"],"award-info":[{"award-number":["R01 #HL155718-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>The sympathetic nervous system (SNS) consists largely of two different types of components: neurons that release the neurotransmitter norepinephrine (NE, noradrenaline) to modulate homeostasis of the innevrvated effector organ or tissue and adrenal chromaffin cells, which synthesize and secrete the hormone epinephrine (Epi, adrenaline) and some NE into the blood circulation to act at distant organs and tissues that are not directly innervated by the SNS. Like almost every physiological process in the human body, G protein-coupled receptors (GPCRs) tightly modulate both NE release from sympathetic neuronal terminals and catecholamine (CA) secretion from the adrenal medulla. Regulator of G protein Signaling (RGS) proteins, acting as guanosine triphosphatase (GTPase)-activating proteins (GAPs) for the G\u03b1 subunits of heterotrimeric guanine nucleotide-binding proteins (G proteins), play a central role in silencing G protein signaling from a plethora of GPCRs. Certain RGS proteins and, in particular, RGS4, have been implicated in regulation of SNS activity and of adrenal chromaffin cell CA secretion. More specifically, recent studies have implicated RGS4 in regulation of NE release from cardiac sympathetic neurons by means of terminating free fatty acid receptor (FFAR)-3 calcium signaling and in regulation of NE and Epi secretion from the adrenal medulla by means of terminating cholinergic calcium signaling in adrenal chromaffin cells. Thus, in this review, we provide an overview of the current literature on the involvement of RGS proteins, with a particular focus on RGS4, in these two processes, i.e., NE release from sympathetic nerve terminals &amp; CA secretion from adrenal chromaffin cells. We also highlight the therapeutic potential of RGS4 pharmacological manipulation for diseases characterized by sympathetic dysfunction or SNS hyperactivity, such as heart failure and hypertension.<\/jats:p>","DOI":"10.31083\/j.fbl2910355","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T07:40:52Z","timestamp":1730274052000},"source":"Crossref","is-referenced-by-count":2,"title":["RGS Proteins in Sympathetic Nervous System Regulation: Focus on Adrenal RGS4"],"prefix":"10.31083","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9817-6319","authenticated-orcid":true,"given":"Anastasios","family":"Lymperopoulos","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Laboratory for the Study of Neurohormonal Control of the Circulation, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Davie\/Fort Lauderdale, FL 33328-2018, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee A.","family":"Stoicovy","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Laboratory for the Study of Neurohormonal Control of the Circulation, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Davie\/Fort Lauderdale, FL 33328-2018, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Desimine VL, McCrink KA, Parker BM, Wertz SL, Maning J, Lymperopoulos A. Biased Agonism\/Antagonism of Cardiovascular GPCRs for Heart Failure Therapy. International Review of Cell and Molecular Biology. 2018; 339: 41\u201361.","DOI":"10.1016\/bs.ircmb.2018.02.007"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Sriram K, Insel PA. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? Molecular Pharmacology. 2018; 93: 251\u2013258.","DOI":"10.1124\/mol.117.111062"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ferraino KE, Cora N, Pollard CM, Sizova A, Maning J, Lymperopoulos A. Adrenal angiotensin II type 1 receptor biased signaling: The case for \u201cbiased\u201d inverse agonism for effective aldosterone suppression. Cellular Signalling. 2021; 82: 109967.","DOI":"10.1016\/j.cellsig.2021.109967"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Congreve M, de Graaf C, Swain NA, Tate CG. Impact of GPCR Structures on Drug Discovery. Cell. 2020; 181: 81\u201391.","DOI":"10.1016\/j.cell.2020.03.003"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Lymperopoulos A, Brill A, McCrink KA. GPCRs of adrenal chromaffin cells & catecholamines: The plot thickens. The International Journal of Biochemistry & Cell Biology. 2016; 77: 213\u2013219.","DOI":"10.1016\/j.biocel.2016.02.003"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lefkowitz RJ. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends in Pharmacological Sciences. 2004; 25: 413\u2013422.","DOI":"10.1016\/j.tips.2004.06.006"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Philipp M, Hein L. Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacology & Therapeutics. 2004; 101: 65\u201374.","DOI":"10.1016\/j.pharmthera.2003.10.004"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Lymperopoulos A, Rengo G, Funakoshi H, Eckhart AD, Koch WJ. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nature Medicine. 2007; 13: 315\u2013323.","DOI":"10.1038\/nm1553"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Jafferjee M, Reyes Valero T, Marrero C, McCrink KA, Brill A, Lymperopoulos A. GRK2 Up-Regulation Creates a Positive Feedback Loop for Catecholamine Production in Chromaffin Cells. Molecular Endocrinology (Baltimore, Md.). 2016; 30: 372\u2013381.","DOI":"10.1210\/me.2015-1305"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Huang CC, Tesmer JJG. Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs. The Journal of Biological Chemistry. 2011; 286: 7715\u20137721.","DOI":"10.1074\/jbc.R109.051847"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Knight KM, Ghosh S, Campbell SL, Lefevre TJ, Olsen RHJ, Smrcka AV, et al. A universal allosteric mechanism for G protein activation. Molecular Cell. 2021; 81: 1384\u20131396.e6.","DOI":"10.1016\/j.molcel.2021.02.002"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Weis WI, Kobilka BK. The Molecular Basis of G Protein-Coupled Receptor Activation. Annual Review of Biochemistry. 2018; 87: 897\u2013919.","DOI":"10.1146\/annurev-biochem-060614-033910"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Sprang SR. Invited review: Activation of G proteins by GTP and the mechanism of G\u03b1-catalyzed GTP hydrolysis. Biopolymers. 2016; 105: 449\u2013462.","DOI":"10.1002\/bip.22836"},{"key":"ref14","unstructured":"Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacological Reviews. 2001; 53: 1\u201324."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Lymperopoulos A, Suster MS, Borges JI. Cardiovascular GPCR regulation by regulator of G protein signaling proteins. Progress in Molecular Biology and Translational Science. 2022; 193: 145\u2013166.","DOI":"10.1016\/bs.pmbts.2022.06.006"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circulation Research. 2005; 96: 401\u2013411.","DOI":"10.1161\/01.RES.0000158287.49872.4e"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Zhang P, Mende U. Regulators of G-protein signaling in the heart and their potential as therapeutic targets. Circulation Research. 2011; 109: 320\u2013333.","DOI":"10.1161\/CIRCRESAHA.110.231423"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Perschbacher KJ, Deng G, Fisher RA, Gibson-Corley KN, Santillan MK, Grobe JL. Regulators of G protein signaling in cardiovascular function during pregnancy. Physiological Genomics. 2018; 50: 590\u2013604.","DOI":"10.1152\/physiolgenomics.00037.2018"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Squires KE, Monta\u00f1ez-Miranda C, Pandya RR, Torres MP, Hepler JR. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease. Pharmacological Reviews. 2018; 70: 446\u2013474.","DOI":"10.1124\/pr.117.015354"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"McNeill SM, Zhao P. The roles of RGS proteins in cardiometabolic disease. British Journal of Pharmacology. 2024; 181: 2319\u20132337.","DOI":"10.1111\/bph.16076"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Masuho I, Balaji S, Muntean BS, Skamangas NK, Chavali S, Tesmer JJG, et al. A Global Map of G Protein Signaling Regulation by RGS Proteins. Cell. 2020; 183: 503\u2013521.e19.","DOI":"10.1016\/j.cell.2020.08.052"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Lymperopoulos A, Borges JI, Stoicovy RA. RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting. Biochemical Pharmacology. 2023; 218: 115904.","DOI":"10.1016\/j.bcp.2023.115904"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Cho H, Harrison K, Schwartz O, Kehrl JH. The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. The Biochemical Journal. 2003; 371: 973\u2013980.","DOI":"10.1042\/bj20021769"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Neill JD, Duck LW, Sellers JC, Musgrove LC, Scheschonka A, Druey KM, et al. Potential role for a regulator of G protein signaling (RGS3) in gonadotropin-releasing hormone (GnRH) stimulated desensitization. Endocrinology. 1997; 138: 843\u2013846.","DOI":"10.1210\/endo.138.2.5034"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Gross V, Tank J, Obst M, Plehm R, Blumer KJ, Diedrich A, et al. Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2005; 288: R1134\u2013R1142.","DOI":"10.1152\/ajpregu.00246.2004"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Obst M, Tank J, Plehm R, Blumer KJ, Diedrich A, Jordan J, et al. NO-dependent blood pressure regulation in RGS2-deficient mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2006; 290: R1012\u2013R1019.","DOI":"10.1152\/ajpregu.00288.2005"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Tank J, Obst M, Diedrich A, Brychta RJ, Blumer KJ, Heusser K, et al. Sympathetic nerve traffic and circulating norepinephrine levels in RGS2-deficient mice. Autonomic Neuroscience: Basic & Clinical. 2007; 136: 52\u201357.","DOI":"10.1016\/j.autneu.2007.04.001"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hercule HC, Tank J, Plehm R, Wellner M, da Costa Goncalves AC, Gollasch M, et al. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice. Experimental Physiology. 2007; 92: 1014\u20131022.","DOI":"10.1113\/expphysiol.2007.038240"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Grant SL, Lass\u00e8gue B, Griendling KK, Ushio-Fukai M, Lyons PR, Alexander RW. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Molecular Pharmacology. 2000; 57: 460\u2013467.","DOI":"10.1124\/mol.57.3.460"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Xie Z, Gong MC, Su W, Turk J, Guo Z. Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells. The Journal of Biological Chemistry. 2007; 282: 25278\u201325289.","DOI":"10.1074\/jbc.M611206200"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Xie Z, Liu D, Liu S, Calderon L, Zhao G, Turk J, et al. Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles. The Journal of Biological Chemistry. 2011; 286: 44646\u201344658.","DOI":"10.1074\/jbc.M111.265462"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Wu Y, Nakagawa S, Takahashi H, Kawabata Y, Suzuki E, Uehara Y. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats. Hypertension Research: Official Journal of the Japanese Society of Hypertension. 2016; 39: 295\u2013301.","DOI":"10.1038\/hr.2015.154"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Borges JI, Suster MS, Lymperopoulos A. Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4. International Journal of Molecular Sciences. 2023; 24: 6136.","DOI":"10.3390\/ijms24076136"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proceedings of the National Academy of Sciences of the United States of America. 2011; 108: 8030\u20138035.","DOI":"10.1073\/pnas.1016088108"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Borges JI, Ferraino KE, Cora N, Nagliya D, Suster MS, Carbone AM, et al. Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair. Journal of Cardiovascular Pharmacology. 2022; 80: 386\u2013392.","DOI":"10.1097\/FJC.0000000000001213"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Xu X, Kaindl J, Clark MJ, H\u00fcbner H, Hirata K, Sunahara RK, et al. Binding pathway determines norepinephrine selectivity for the human \u03b21AR over \u03b22AR. Cell Research. 2021; 31: 569\u2013579.","DOI":"10.1038\/s41422-020-00424-2"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW, 2nd, Koch WJ. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. The Journal of Biological Chemistry. 2010; 285: 16378\u201316386.","DOI":"10.1074\/jbc.M109.077859"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Inoue D, Kimura I, Wakabayashi M, Tsumoto H, Ozawa K, Hara T, et al. Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation. FEBS Letters. 2012; 586: 1547\u20131554.","DOI":"10.1016\/j.febslet.2012.04.021"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Dowal L, Elliott J, Popov S, Wilkie TM, Scarlata S. Determination of the contact energies between a regulator of G protein signaling and G protein subunits and phospholipase C beta 1. Biochemistry. 2001; 40: 414\u2013421.","DOI":"10.1021\/bi001923+"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Zeng W, Xu X, Popov S, Mukhopadhyay S, Chidiac P, Swistok J, et al. The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. The Journal of Biological Chemistry. 1998; 273: 34687\u201334690.","DOI":"10.1074\/jbc.273.52.34687"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacology & Therapeutics. 2007; 116: 473\u2013495.","DOI":"10.1016\/j.pharmthera.2007.09.005"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Carbone AM, Borges JI, Suster MS, Sizova A, Cora N, Desimine VL, et al. Regulator of G-Protein Signaling-4 Attenuates Cardiac Adverse Remodeling and Neuronal Norepinephrine Release-Promoting Free Fatty Acid Receptor FFAR3 Signaling. International Journal of Molecular Sciences. 2022; 23: 5803.","DOI":"10.3390\/ijms23105803"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Huang J, Zhou H, Mahavadi S, Sriwai W, Murthy KS. Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2. American Journal of Physiology. Cell Physiology. 2007; 292: C200\u2013C208.","DOI":"10.1152\/ajpcell.00103.2006"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Tokudome T, Kishimoto I, Horio T, Arai Y, Schwenke DO, Hino J, et al. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart. Circulation. 2008; 117: 2329\u20132339.","DOI":"10.1161\/CIRCULATIONAHA.107.732990"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketones and the Heart: Metabolic Principles and Therapeutic Implications. Circulation Research. 2023; 132: 882\u2013898.","DOI":"10.1161\/CIRCRESAHA.123.321872"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Kawakami R, Matsui H, Matsui M, Iso T, Yokoyama T, Ishii H, et al. Empagliflozin induces the transcriptional program for nutrient homeostasis in skeletal muscle in normal mice. Scientific Reports. 2023; 13: 18025.","DOI":"10.1038\/s41598-023-45390-y"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Benovic JL. Historical Perspective of the G Protein-Coupled Receptor Kinase Family. Cells. 2021; 10: 555.","DOI":"10.3390\/cells10030555"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Kayki-Mutlu G, Koch WJ. Novel roles for G protein-coupled receptor kinases in cardiac injury and repair. Biochemical Society Transactions. 2023; 51: 715\u2013724.","DOI":"10.1042\/BST20221317"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Mutafova-Yambolieva VN, Smyth L, Bobalova J. Involvement of cyclic AMP-mediated pathway in neural release of noradrenaline in canine isolated mesenteric artery and vein. Cardiovascular Research. 2003; 57: 217\u2013224.","DOI":"10.1016\/S0008-6363(02)00648-X"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Zhang X, Wang N, Fu P, An Y, Sun F, Wang C, et al. Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating \u03b2-Hydroxybutyrate-activated Citrate Synthase. Journal of Cardiovascular Pharmacology. 2023; 82: 375\u2013388.","DOI":"10.1097\/FJC.0000000000001474"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Lymperopoulos A, Del Calvo G, Baggio Lopez T, Carbone A, Borges J, Suster M, et al. Dapagliflozin downregulates G protein-coupled receptor Kinase-2 and upregulates regulator of g protein signaling-4 in adrenals to exert sympatholysis in heart failure. European Heart Journal. 2023; 44: ehad655.3298.","DOI":"10.1093\/eurheartj\/ehad655.3298"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Ohtsuki H, Morita K, Minami N, Suemitsu T, Tsujimoto A, Dohi T. Involvement of Ca2+ entry and inositol trisphosphate-induced internal Ca2+ mobilization in muscarinic receptor-mediated catecholamine release in dog adrenal chromaffin cells. Neurochemistry International. 1992; 21: 259\u2013267.","DOI":"10.1016\/0197-0186(92)90156-L"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Carbone E, Borges R, Eiden LE, Garc\u00eda AG, Hern\u00e1ndez-Cruz A. Chromaffin Cells of the Adrenal Medulla: Physiology, Pharmacology, and Disease. Comprehensive Physiology. 2019; 9: 1443\u20131502.","DOI":"10.1002\/cphy.c190003"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Lim HJ, Lee SK, Lim DY. Influence of Fimasartan (a Novel AT(1) Receptor Blocker) on Catecholamine Release in the Adrenal Medulla of Spontaneously Hypertensive Rats. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2013; 17: 99\u2013109.","DOI":"10.4196\/kjpp.2013.17.1.99"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Santana A, Est\u00e9vez-Herrera J, Seward EP, Borges R, Machado JD. Glucagon-like peptide-1 receptor controls exocytosis in chromaffin cells by increasing full-fusion events. Cell Reports. 2021; 36: 109609.","DOI":"10.1016\/j.celrep.2021.109609"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Cortez V, Santana M, Marques AP, Mota A, Rosmaninho-Salgado J, Cavadas C. Regulation of catecholamine release in human adrenal chromaffin cells by \u03b2-adrenoceptors. Neurochemistry International. 2012; 60: 387\u2013393.","DOI":"10.1016\/j.neuint.2011.12.018"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Iankova I, Chavey C, Clap\u00e9 C, Colomer C, Gu\u00e9rineau NC, Grillet N, et al. Regulator of G protein signaling-4 controls fatty acid and glucose homeostasis. Endocrinology. 2008; 149: 5706\u20135712.","DOI":"10.1210\/en.2008-0717"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Pollard CM, Ghandour J, Cora N, Perez A, Parker BM, Desimine VL, et al. GRK2-Mediated Crosstalk Between \u03b2-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo. International Journal of Molecular Sciences. 2020; 21: 574.","DOI":"10.3390\/ijms21020574"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Mathieu NM, Nakagawa P, Grobe JL, Sigmund CD. Insights Into the Role of Angiotensin-II AT1 Receptor-Dependent \u03b2-Arrestin Signaling in Cardiovascular Disease. Hypertension (Dallas, Tex.: 1979). 2024; 81: 6\u201316.","DOI":"10.1161\/HYPERTENSIONAHA.123.19419"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Liu CH, Gong Z, Liang ZL, Liu ZX, Yang F, Sun YJ, et al. Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling. Nature Communications. 2017; 8: 14335.","DOI":"10.1038\/ncomms14335"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Ubeysinghe S, Wijayaratna D, Kankanamge D, Karunarathne A. Molecular regulation of PLC\u03b2 signaling. Methods in Enzymology. 2023; 682: 17\u201352.","DOI":"10.1016\/bs.mie.2023.01.001"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Parys JB, Lemos FO. The interplay between associated proteins, redox state and Ca2+ in the intraluminal ER compartment regulates the IP3 receptor. Cell Calcium. 2024; 117: 102823.","DOI":"10.1016\/j.ceca.2023.102823"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Lipp P, Reither G. Protein kinase C: the \u201cmasters\u201d of calcium and lipid. Cold Spring Harbor Perspectives in Biology. 2011; 3: a004556.","DOI":"10.1101\/cshperspect.a004556"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"de Diego AMG, Gand\u00eda L, Garc\u00eda AG. A physiological view of the central and peripheral mechanisms that regulate the release of catecholamines at the adrenal medulla. Acta Physiologica (Oxford, England). 2008; 192: 287\u2013301.","DOI":"10.1111\/j.1748-1716.2007.01807.x"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Sala F, Nistri A, Criado M. Nicotinic acetylcholine receptors of adrenal chromaffin cells. Acta Physiologica (Oxford, England). 2008; 192: 203\u2013212.","DOI":"10.1111\/j.1748-1716.2007.01804.x"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Harada K, Matsuoka H, Miyata H, Matsui M, Inoue M. Identification of muscarinic receptor subtypes involved in catecholamine secretion in adrenal medullary chromaffin cells by genetic deletion. British Journal of Pharmacology. 2015; 172: 1348\u20131359.","DOI":"10.1111\/bph.13011"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Romero DG, Zhou MY, Yanes LL, Plonczynski MW, Washington TR, Gomez-Sanchez CE, et al. Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion. The Journal of Endocrinology. 2007; 194: 429\u2013440.","DOI":"10.1677\/JOE-07-0153"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Romero DG, Plonczynski MW, Gomez-Sanchez EP, Yanes LL, Gomez-Sanchez CE. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. Endocrinology. 2006; 147: 3889\u20133897.","DOI":"10.1210\/en.2005-1532"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Florea VG, Cohn JN. The autonomic nervous system and heart failure. Circulation Research. 2014; 114: 1815\u20131826.","DOI":"10.1161\/CIRCRESAHA.114.302589"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Weber KT. Aldosterone in congestive heart failure. The New England Journal of Medicine. 2001; 345: 1689\u20131697.","DOI":"10.1056\/NEJMra000050"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Jiang Y, Choi WH, Lee JH, Han DH, Kim JH, Chung YS, et al. A neurostimulant para-chloroamphetamine inhibits the arginylation branch of the N-end rule pathway. Scientific Reports. 2014; 4: 6344.","DOI":"10.1038\/srep06344"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/10\/10.31083\/j.fbl2910355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T14:56:23Z","timestamp":1732719383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/10\/10.31083\/j.fbl2910355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2768-6701(24)01434-5"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2910355","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"article-number":"355"}}